Abstract
Abstract
Objective
Sex, age, and education are associated with the level of cognitive performance. We investigated whether these factors modulate the change in cognitive performance in midlife by leveraging the longitudinal data from the Cardiovascular Risk in Young Finns Study (YFS).
Methods
Participants of the YFS cohort performed a computer-based Cambridge Neuropsychological Test Automated Battery (CANTAB) in 2011 and 2018 (n = 1671, age 41–56 years in 2018). Overall cognitive performance and domains representing learning and memory, working memory, reaction time, and information processing were extracted by common principal component analysis from the longitudinal cognitive data. Linear models adjusted for baseline cognitive performance were used to study the association of sex, age, and education with changes in overall cognitive performance and in the cognitive domains.
Results
Cognitive performance decreased in all domains (overall cognition -0.56 SD, p < 0.001; working memory -0.81 SD, p < 0.001; learning and memory -0.70 SD, p < 0.001; reaction time -0.06 SD, p = 0.019; information processing -0.03 SD, p = 0.016). The decrease in working memory and information processing was greater in females compared to males. Cognitive performance decreased more in older participants in all domains. Education alleviated the decrease in cognitive performance in all domains except reaction time. The beneficial effect of education was greater for males.
Conclusions
This study describes the natural course of aging-related changes in cognitive performance in midlife, the critical time window for early prevention of clinical cognitive decline. These findings provide a reference for studies focusing on determinants of pathological cognitive decline deviating from normal changes in cognitive performance.
Funder
Horizon 2020
European Research Council
Tampere University Hospital Supporting Foundation
Academy of Finland
Kela
Competitive State Research Financing of the Expert Responsibility area of Kuopio
Tampere and Turku University Hospitals
Juho Vainion Säätiö
Paavo Nurmen Säätiö
Sydäntutkimussäätiö
Suomen Kulttuurirahasto
Sigrid Juséliuksen Säätiö
Tampereen Tuberkuloosisäätiö
Emil Aaltosen Säätiö
Yrjö Jahnssonin Säätiö
Signe ja Ane Gyllenbergin Säätiö
Jenny ja Antti Wihurin Rahasto
Diabetestutkimussäätiö
University of Turku
Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. Rowe JW, Kahn RL (2000) Successful aging and disease prevention. Adv Ren Replace Ther 7:70–77
2. Porsteinsson AP, Isaacson RS, Knox S, Sabbagh MN, Rubino I (2021) Diagnosis of early Alzheimer’s disease: clinical practice in 2021. J Prev Alzheimers Dis 8:371–386
3. Jack CR, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS et al (2013) Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 12:207–216
4. Morris JC (2005) Early-stage and preclinical Alzheimer disease. Alzheimer Dis Assoc Disord 19:163–165
5. Jack CR, Holtzman DM (2013) Biomarker modeling of Alzheimer’s disease. Neuron 80:1347–1358